[A critical analysis of survival in idiopathic pulmonary arterial hypertension]
- PMID: 20732617
- DOI: 10.1016/S0755-4982(10)70006-3
[A critical analysis of survival in idiopathic pulmonary arterial hypertension]
Abstract
Idiopathic pulmonary arterial hypertension (PAH) is a rare disease characterized by a progressive increase in pulmonary vascular resistance leading to right heart failure and death. Recent survival data in PAH cohorts have been biased by the inclusion of prevalent patients ("survivors") who have a better prognosis than incident cases. Nevertheless, a critical analysis of recent multicenter incident cohorts has shown survival improvements in the current management era, thanks to better management. However idiopathic PAH remains a severe disease with a poor prognosis. Current recommendations emphasize the necessity of an aggressive goal-oriented management of symptomatic PAH. Modern survival figures also highlight the relevance of lung transplantation in eligible PAH patients refractory to current best standard of care.
Similar articles
-
A critical analysis of survival in pulmonary arterial hypertension.Eur Respir Rev. 2012 Sep 1;21(125):218-22. doi: 10.1183/09059180.00003512. Eur Respir Rev. 2012. PMID: 22941886 Free PMC article. Review.
-
Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies.J Am Coll Cardiol. 2014 May 27;63(20):2159-2169. doi: 10.1016/j.jacc.2014.02.575. Epub 2014 Mar 26. J Am Coll Cardiol. 2014. PMID: 24681143
-
[Treatment goals in pulmonary arterial hypertension].Presse Med. 2010 Jun;39 Suppl 1:1S33-40. doi: 10.1016/S0755-4982(10)70005-1. Presse Med. 2010. PMID: 20732616 French.
-
Current therapies for pulmonary arterial hypertension.Semin Cardiothorac Vasc Anesth. 2007 Jun;11(2):137-48. doi: 10.1177/1089253207301356. Semin Cardiothorac Vasc Anesth. 2007. PMID: 17536117 Review.
-
Complications leading to sudden cardiac death in pulmonary arterial hypertension.Respir Care. 2013 Jul;58(7):1246-54. doi: 10.4187/respcare.02252. Epub 2012 Dec 27. Respir Care. 2013. PMID: 23271814 Review.
Cited by
-
Cardiac Arrhythmias in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Mechanistic Insights, Pathophysiology, and Outcomes.Ann Noninvasive Electrocardiol. 2024 Sep;29(5):e70010. doi: 10.1111/anec.70010. Ann Noninvasive Electrocardiol. 2024. PMID: 39205610 Free PMC article. Review.
-
Predictors of poor outcome in patients with pulmonary arterial hypertension: A single center study.PLoS One. 2018 Apr 23;13(4):e0193245. doi: 10.1371/journal.pone.0193245. eCollection 2018. PLoS One. 2018. PMID: 29684090 Free PMC article.
-
Arrhythmias in pulmonary arterial hypertension.Prog Cardiovasc Dis. 2012 Sep-Oct;55(2):180-6. doi: 10.1016/j.pcad.2012.06.002. Prog Cardiovasc Dis. 2012. PMID: 23009914 Free PMC article. Review.
-
Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Pulm Circ. 2019 Jan-Mar;9(1):2045894019834890. doi: 10.1177/2045894019834890. Pulm Circ. 2019. PMID: 30747032 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical